Sunshine Biopharma (SBFM) Total Liabilities (2016 - 2025)
Historic Total Liabilities for Sunshine Biopharma (SBFM) over the last 14 years, with Q3 2025 value amounting to $7.3 million.
- Sunshine Biopharma's Total Liabilities rose 4525.2% to $7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year increase of 4525.2%. This contributed to the annual value of $7.1 million for FY2024, which is 1498.53% up from last year.
- Sunshine Biopharma's Total Liabilities amounted to $7.3 million in Q3 2025, which was up 4525.2% from $6.3 million recorded in Q2 2025.
- In the past 5 years, Sunshine Biopharma's Total Liabilities registered a high of $7.6 million during Q4 2022, and its lowest value of $95234.0 during Q1 2022.
- In the last 5 years, Sunshine Biopharma's Total Liabilities had a median value of $5.7 million in 2023 and averaged $4.7 million.
- Its Total Liabilities has fluctuated over the past 5 years, first tumbled by 9676.39% in 2022, then skyrocketed by 784030.49% in 2023.
- Over the past 5 years, Sunshine Biopharma's Total Liabilities (Quarter) stood at $2.0 million in 2021, then skyrocketed by 282.49% to $7.6 million in 2022, then decreased by 19.39% to $6.1 million in 2023, then increased by 14.99% to $7.1 million in 2024, then grew by 3.24% to $7.3 million in 2025.
- Its Total Liabilities stands at $7.3 million for Q3 2025, versus $6.3 million for Q2 2025 and $6.5 million for Q1 2025.